Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure

Journal of the American College of Cardiology

Volumn 28, Issue 1, 1996, Pages 176-182

  Elkayam, Uri ^a   Cohen, Gregory ^a   Gogia, Harinder ^a   Mehra, Anilkumar ^a   Johnson, Janet V ^a   Chandraratna, P Anthony N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GLYCERYL TRINITRATE;

ADULT; ARTERY ENDOTHELIUM; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; HUMAN; KIDNEY BLOOD FLOW; MALE; PRIORITY JOURNAL; RENAL ARTERY; STATISTICAL ANALYSIS; VASODILATATION;

EID: 0030199275     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00092-7     Document Type: Article

References (36)

1. 1. Leier CV, Magorien RD, Desch CE, Thompson MJ, Unverferth DV. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination. Circulation 1981;63:102-9.
2. 2. Cody RJ, Ljungman S, Covit AB, et al. Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 1988;34:361-37.
3. 3. Leier CV, Dei Cas L, Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia and hypomagnesemia. Am Heart J 1994;128:564-74.
4. 4. Leithe ME, Margorien RD, Hermiller JB, Unverferth DV, Leier CV. Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 1984;69:57-64.
5. 5. Leier CV, Bambach D, Thompson MJ, Cattaneo SM, Goldberg RJ, Unverferth DV. Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure. Am J Cardiol 1981;48:1115-23.
6. 6. Elkayam U, Weber L, Campese VM, Massry SG, Rahimtoola SH. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure. J Am Coll Cardiol 1984;4:1261-7.
7. 7. Jamison M, Widerhorn J, Weber L, et al. Central and renal hemodynamic effects of a new agonist at peripheral dopamine and beta 2 adrenoreceptors (dopexamine) in patients with heart failure. Am Heart J 1989;117:607-14.
8. 8. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in relaxation of arterial smooth muscle by acetylcholine. Nature 1980;2:373-6.
9. 9. Luscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton: CRC Press, 1990:1-215.
10. 10. Radermacher J, Forstermann U, Frolich JC. Endothelium-derived relaxing factor influences renal vascular resistance. Am J Physiol 1990;259:F9-F17.
11. 11. Luscher TF, Bock HA. The endothelial L-arginine/nitric oxide pathway and the renal circulation. Klin Wochenschr 1991;69:603-9.
12. 12. Romero JC, Lahera V, Salom MG, Biondi ML. Role of the endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol l992;2:1371-87.
13. 13. Chen C, Mitchell KD, Navar LG. Role of endothelium-derived nitric oxide in the renal hemodynamic response to amino acid infusion. Am J Physiol 1992;263:R510-6.
14. 14. Lahera V, Salom MG, Fiksen-Olsen MJ, Romero JC. Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effect of bradykinin. Am J Hypertens 1991;4:260-2.
15. 15. Lahera V, Salom MG, Miranda-Guardiola F, Moncada S, Romero JC. Effects of N-nitro-L-arginine methylester on renal function and blood pressure. Am J Physiol 1991;261:F1033-F1037.
16. 16. Raij L. Nitric oxide and the kidney. Circulation 1993;87 Suppl V:V-26-V-29.
17. 17. Luscher TF, Cooke JP, Houston DS, Neves RJ, Vanhoutte PM. Endothelium-dependent relaxations in human arteries. Mayo Clin Proc 1987;62:601-6.
18. 18. Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance and strategies for prevention. Ann Intern Med 1990;114:667-77.
19. 19. Treasure CB, Vita JA, Cox DA, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990;81:772-9.
20. 20. Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1982;19:918-25.
21. 21. Louis TA, Lavori PW, Bailar JC, Polansky M. Crossover and self-controlled designs in clinical research. In: Bailar JC, Mosteller F, editors. Medical Uses of Statistics. 2nd ed. Boston (MA): New England Journal of Medicine Books, 1992:83-103.
22. 22. Oriji G, Gill JR, Yun JC, Keiser H. Role of prostacyclin in the renal response to acetylcholine. Renal Physiol Biochem 1992;15:318-24.
23. 23. Tolins JP, Palmer RMJ, Moncada S, Raij L. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 1990;258:H655-H662.
24. G-monomethyl L-arginine and L-arginine on acetylcholine renal response. Hypertension 1990;15:659-63.
25. 25. Zatz R, DeNucci G. Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 1991;261:F360-F363.
26. 26. Kon V, Harris RC, Ichikawa L. A regulatory role for large vessels in organ circulation endothelial cells of the main renal artery modulate intrarenal hemodynamics in the rat. J Clin Invest 1990;85:1728-32.
27. 27. Radermacher J, Rorstermarm U, Frolich JC. Endothelium-derived relaxing factor influences renal vascular resistance. Am J Physiol 1990;259:F9-F17.
28. 28. Okumura M, Miura K, Yamashita Y, Yukimura T, Yamamato K. Role of endothelium-derived relaxing factor in the in vitro renal vascular action of adenosine in dogs. J Pharmacol Exp Ther 1992;260:1262-7.
29. 29. Mehta JL. Endothelium, coronary vasodilation and organic nitrates. Am Heart J 1995;129:382-91.
30. 30. Chung SH, Fung HL. Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells. J Pharmacol Exp Ther 1990;253:614-9.
31. 31. Anderson TJ, Meredith IT, Ganz P, Selwyn AP, Yeung AC. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol 1994;24:555-66.
32. 32. Fung HL, Chung SJ, Bauer JA, Chong S, Kowaluk EA. Biochemical mechanism of organic nitrate action. Am J Cardiol 1992;70:4B-10B.
33. 33. Flaim SF. Peripheral vascular effects of nitroglycerin in a conscious rat model of heart failure. Am J Physiol 1982;243:H974-H981.
34. 34. Sellke FW, Tomanek RJ, Harrison DG. L-cysteine selectively potentiates nitroglycerin-induced dilation of small coronary microvessels. J Pharmacol Exp Ther 1991;258:365-9.
35. 35. Kurtz MA, Lamping KG, Bates JN, Eastham CL, Marcus ML, Harrison DG. Mechanisms responsible for the heterogenous coronary microvascular response to nitroglycerin. Circ Res 1991;68:847-55.
36. 36. Luscher TF, Noll G. Endothelium-dependent vasomotion in aging, hypertension, and heart failure. Circulation 1993;87 Suppl VII:VII-97-103.